Wakefield Asset Management’s Elevance Health ELV Stock Holding History

Wakefield Asset Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.55M	Hold	4,000	–	–	0.35%	87
2026 Q1	$1.17M	Hold	4,000	–	–	0.31%	95
2025 Q4	$1.4M	Hold	4,000	–	–	0.38%	78
2025 Q3	$1.29M	Hold	4,000	–	–	0.35%	91
2025 Q2	$1.56M	Hold	4,000	–	–	0.43%	70
2025 Q1	$1.74M	Buy	+4,000	New	+$1.61M	0.53%	63
2019 Q4	–	Sell	-4,163	Closed	-$1M	–	167
2019 Q3	$1M	Sell	4,163 -5,592	-57%	-$1.53M	0.44%	67
2019 Q2	$2.75M	Sell	9,755 -763	-7%	-$208K	1.09%	38
2019 Q1	$3.02M	Buy	+10,518	New	+$3.04M	1.09%	33

Other funds holding ELV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Wakefield Asset Management's ELV Position: Q2 2026 in Review

Wakefield Asset Management held its Elevance Health (ELV) position steady in Q2 2026 at 4,000 shares worth $1.55M. The position accounts for 0.35% of the portfolio, ranked #87.

Wakefield Asset Management first reported a position in ELV in Q1 2019 and has held it in 9 quarters since. The position peaked at $3.02M in Q1 2019. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

Wakefield Asset Management held 4,000 shares of Elevance Health worth $1.55M as of Q2 2026.
Wakefield Asset Management left its Elevance Health share count unchanged in Q2 2026.
Elevance Health made up 0.35% of Wakefield Asset Management's portfolio in Q2 2026, its #87 holding.
Wakefield Asset Management first reported a position in Elevance Health in Q1 2019 and has held it in 9 quarters since.
Wakefield Asset Management's Elevance Health position peaked at $3.02M in Q1 2019.
1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Wakefield Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.